- Home
- SIBN
SIBN
SI-BONE Inc.
as 02-21-2025 4:00pm EST
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Upcoming Earnings Alert:
Get ready for potential market movements as SI-BONE Inc. SIBN prepares to release earnings report on 24 Feb 2025.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 547.3M | IPO Year: | 2018 |
| Target Price: | $23.00 | AVG Volume (30 days): | 301.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.70 - $20.74 | Next Earning Date: | 02-24-2025 |
| Revenue: | $157,035,000 | Revenue Growth: | 18.98% |
| Revenue Growth (this year): | 21.89% | Revenue Growth (next year): | 16.65% |
Stock Insider Trading Activity of SI-BONE Inc. (SIBN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DUNN JEFFREY W | SIBN | Director | Feb 3 '25 | Sell | $16.51 | 337 | $5,562.39 | 17,290 | |
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Jan 2 '25 | Sell | $13.90 | 3,670 | $51,014.14 | 224,540 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Jan 2 '25 | Sell | $13.91 | 5,304 | $73,802.05 | 192,989 |
Latest SI-BONE Inc. News
SIBN Breaking Stock News: Dive into SIBN Ticker-Specific Updates for Smart Investing
MT Newswires
20 hours ago
Si-Bone Insider Sold Shares Worth $795,915, According to a Recent SEC Filing
Zacks
5 days ago
Si-Bone (SIBN) Expected to Beat Earnings Estimates: Should You Buy?
Simply Wall St.
18 days ago
SI-BONE (NASDAQ:SIBN) shareholders have endured a 20% loss from investing in the stock five years ago
GlobeNewswire
19 days ago
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025
TipRanks
a month ago
SI-Bone price target raised to $20 from $19 at Needham
GlobeNewswire
a month ago
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024
Zacks
2 months ago
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.71%: Here's is How to Trade
Zacks
3 months ago
Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?
Compare SIBN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SIBN SI-BONE Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.